Women in clinical trials: concluding remarks.
D000028:Abortion, Induced; D000163:Acquired Immunodeficiency Syndrome; D000367:Age Factors; D003267:Contraception; D003657:Decision Making; D064420:Drug-Related Side Effects and Adverse Reactions; D015507:Drugs, Investigational; D004864:Equipment and Supplies; D035082:Federal Government; D005260:Female; D005333:Fetus; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006806:Human Rights; D006801:Humans; D008571:Men; D009369:Neoplasms; D010358:Patient Participation; D018579:Patient Selection; D011247:Pregnancy; D037841:Pregnant People; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration; D014930:Women
Biomedical and Behavioral Research; Legal Approach